Advertisement
Screener

GLOBUS MEDICAL, INC. (GMED) Share-based Payment Arrangement, Expensed and Capitalized, Amount

2.8 / 5 stars · 68/120 Roast Me

GLOBUS MEDICAL, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount

GLOBUS MEDICAL, INC. (GMED) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $13.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2026-08-06

  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-06-30 was $13.42M, a 66.92% decline year-over-year.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-03-31 was $12.79M, a 4.02% decline year-over-year.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-12-31 was $11.35M, a 4.27% decline year-over-year.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-09-30 was $11.51M, a 6.46% decline year-over-year.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2025 was $76.53M, a 40.98% increase from fiscal 2024.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2024 was $54.29M, a 2.87% increase from fiscal 2023.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2023 was $52.77M, a 57.69% increase from fiscal 2022.
  • GLOBUS MEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2022 was $33.47M, a 7.08% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expensed and Capitalized, Amount 3 monthShare-based Payment Arrangement, Expensed and Capitalized, Amount 3 month as first filedShare-based Payment Arrangement, Expensed and Capitalized, Amount 6 monthShare-based Payment Arrangement, Expensed and Capitalized, Amount 9 monthShare-based Payment Arrangement, Expensed and Capitalized, Amount 9 month as first filedShare-based Payment Arrangement, Expensed and Capitalized, Amount 12 month
2026-06-30$13.42M
10-Q · filed 2026-08-06
$26.21M
10-Q · filed 2026-08-06
$37.56M
derived: sum of 3 quarters · filed 2026-08-06
$49.07M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$12.79M
10-Q · filed 2026-05-07
$24.14M
derived: sum of 2 quarters · filed 2026-05-07
$35.65M
derived: sum of 3 quarters · filed 2026-05-07
$76.23M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$11.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$22.86M
derived: sum of 2 quarters · filed 2026-02-24
$63.44M
derived: sum of 3 quarters · filed 2026-08-06
$76.53M
10-K · filed 2026-02-24
2025-09-30$11.51M
10-Q · filed 2025-11-06
$52.09M
derived: sum of 2 quarters · filed 2026-08-06
$65.18M
10-Q · filed 2025-11-06
$77.27M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$40.58M
10-Q · filed 2026-08-06
$53.67M
10-Q · filed 2026-08-06
$65.77M
derived: sum of 3 quarters · filed 2026-08-06
$78.07M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$13.32M
10-Q · filed 2026-05-07
$25.18M
derived: sum of 2 quarters · filed 2026-05-07
$37.48M
derived: sum of 3 quarters · filed 2026-05-07
$50.33M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$11.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$24.16M
derived: sum of 2 quarters · filed 2026-02-24
$37.01M
derived: sum of 3 quarters · filed 2026-02-24
$54.29M
10-K · filed 2026-02-24
2024-09-30$12.30M
10-Q · filed 2025-11-06
$25.15M
derived: sum of 2 quarters · filed 2025-11-06
$42.43M
10-Q · filed 2025-11-06
$54.77M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$12.84M
10-Q · filed 2025-08-07
$30.13M
10-Q · filed 2025-08-07
$42.47M
derived: sum of 3 quarters · filed 2026-02-24
$65.23M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$17.28M
10-Q · filed 2025-05-08
$29.63M
derived: sum of 2 quarters · filed 2026-02-24
$52.38M
derived: sum of 3 quarters · filed 2026-02-24
$61.02M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$12.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$35.10M
derived: sum of 2 quarters · filed 2026-02-24
$43.74M
derived: sum of 3 quarters · filed 2026-02-24
$52.77M
10-K · filed 2026-02-24
2023-09-30$22.76M
10-Q · filed 2024-11-05
$31.39M
derived: sum of 2 quarters · filed 2024-11-05
$40.43M
10-Q · filed 2024-11-05
$49.09M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$8.64M
10-Q · filed 2024-08-06
$17.67M
10-Q · filed 2024-08-06
$26.33M
derived: sum of 3 quarters · filed 2025-02-20
$34.77M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$9.03M
10-Q · filed 2024-05-07
$17.69M
derived: sum of 2 quarters · filed 2025-02-20
$26.13M
derived: sum of 3 quarters · filed 2025-02-20
$34.15M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$8.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$17.09M
derived: sum of 2 quarters · filed 2025-02-20
$25.11M
derived: sum of 3 quarters · filed 2025-02-20
$33.47M
10-K · filed 2025-02-20
2022-09-30$8.43M
10-Q · filed 2023-11-07
$16.45M
derived: sum of 2 quarters · filed 2023-11-07
$24.81M
10-Q · filed 2023-11-07
$32.77M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$8.02M
10-Q · filed 2023-08-03
$16.37M
10-Q · filed 2023-08-03
$24.34M
derived: sum of 3 quarters · filed 2024-02-21
$31.96M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$8.35M
10-Q · filed 2023-05-04
$16.31M
derived: sum of 2 quarters · filed 2024-02-21
$23.93M
derived: sum of 3 quarters · filed 2024-02-21
$31.72M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$7.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$15.58M
derived: sum of 2 quarters · filed 2024-02-21
$23.37M
derived: sum of 3 quarters · filed 2024-02-21
$31.25M
10-K · filed 2024-02-21
2021-09-30$7.62M
10-Q · filed 2022-11-08
$15.41M
derived: sum of 2 quarters · filed 2022-11-08
$23.29M
10-Q · filed 2022-11-08
$29.29M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$7.79M
10-Q · filed 2022-08-04
$15.67M
10-Q · filed 2022-08-04
$21.67M
derived: sum of 3 quarters · filed 2023-02-21
$28.67M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31$7.88M
10-Q · filed 2022-05-10
$13.88M
derived: sum of 2 quarters · filed 2023-02-21
$20.89M
derived: sum of 3 quarters · filed 2023-02-21
$28.31M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$13.00M
derived: sum of 2 quarters · filed 2023-02-21
$20.43M
derived: sum of 3 quarters · filed 2023-02-21
$27.33M
10-K · filed 2023-02-21
2020-09-30$7.01M
10-Q · filed 2021-11-04
$14.43M
derived: sum of 2 quarters · filed 2021-11-04
$21.34M
10-Q · filed 2021-11-04
$27.85M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$7.43M
10-Q · filed 2021-08-04
$14.33M
10-Q · filed 2021-08-04
$20.84M
derived: sum of 3 quarters · filed 2022-02-17
$26.47M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$6.90M
10-Q · filed 2021-05-04
$13.42M
derived: sum of 2 quarters · filed 2022-02-17
$19.05M
derived: sum of 3 quarters · filed 2022-02-17
$25.43M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$6.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$12.14M
derived: sum of 2 quarters · filed 2022-02-17
$18.53M
derived: sum of 3 quarters · filed 2022-02-17
$26.42M
10-K · filed 2022-02-17
2019-09-30$5.63M
10-Q · filed 2020-10-28
$6.98M
10-Q · filed 2019-11-06
$12.01M
derived: sum of 2 quarters · filed 2020-10-28
$19.90M
10-Q · filed 2020-10-28
$18.55M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30$6.38M
10-Q · filed 2020-08-05
$12.92M
10-Q · filed 2020-08-05
$12.92M
derived: sum of 3 quarters · filed 2021-02-17
$18.55M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31$6.54M
10-Q · filed 2020-05-07
$6.54M
derived: sum of 2 quarters · filed 2021-02-17
$12.17M
derived: sum of 3 quarters · filed 2021-02-17
$17.72M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-31$0.00
derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17
$5.63M
derived: sum of 2 quarters · filed 2021-02-17
$11.18M
derived: sum of 3 quarters · filed 2021-02-17
$22.22M
10-K · filed 2021-02-17
2018-09-30$5.63M
10-Q · filed 2019-11-06
$11.18M
derived: sum of 2 quarters · filed 2019-11-06
$22.22M
10-K · filed 2020-02-20
$17.29M
10-Q · filed 2018-11-08
$21.37M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$5.55M
10-Q · filed 2019-08-01
$11.66M
10-Q · filed 2019-08-01
$15.74M
derived: sum of 3 quarters · filed 2020-03-02
$19.38M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$6.11M
10-Q · filed 2019-05-02
$10.19M
derived: sum of 2 quarters · filed 2020-03-02
$13.83M
derived: sum of 3 quarters · filed 2020-03-02
$17.45M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$4.08M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02
$7.72M
derived: sum of 2 quarters · filed 2020-03-02
$11.34M
derived: sum of 3 quarters · filed 2020-03-02
$14.88M
10-K/A · filed 2020-03-02
2017-09-30$3.65M
10-Q · filed 2018-11-08
$7.26M
derived: sum of 2 quarters · filed 2018-11-08
$10.81M
10-Q · filed 2018-11-08
$13.82M
derived: sum of 4 quarters · filed 2019-02-21
2017-06-30$3.62M
10-Q · filed 2018-08-02
$7.16M
10-Q · filed 2018-08-02
$10.17M
derived: sum of 3 quarters · filed 2019-02-21
$12.98M
derived: sum of 4 quarters · filed 2019-02-21
2017-03-31$3.54M
10-Q · filed 2018-05-03
$6.55M
derived: sum of 2 quarters · filed 2019-02-21
$9.36M
derived: sum of 3 quarters · filed 2019-02-21
$12.35M
derived: sum of 4 quarters · filed 2019-02-21
2016-12-31$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
$5.82M
derived: sum of 2 quarters · filed 2019-02-21
$8.81M
derived: sum of 3 quarters · filed 2019-02-21
$11.65M
10-K · filed 2019-02-21
2016-09-30$2.81M
10-Q · filed 2017-11-09
$5.80M
derived: sum of 2 quarters · filed 2017-11-09
$8.64M
10-Q · filed 2017-11-09
$11.43M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$2.99M
10-Q · filed 2017-08-03
$5.83M
10-Q · filed 2017-08-03
$8.62M
derived: sum of 3 quarters · filed 2018-02-22
$11.02M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$2.84M
10-Q · filed 2017-05-04
$5.63M
derived: sum of 2 quarters · filed 2018-02-22
$8.03M
derived: sum of 3 quarters · filed 2018-02-22
$10.57M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$5.19M
derived: sum of 2 quarters · filed 2018-02-22
$7.73M
derived: sum of 3 quarters · filed 2018-02-22
$9.86M
10-K · filed 2018-02-22
2015-09-30$2.41M
10-Q · filed 2016-11-09
$4.94M
derived: sum of 2 quarters · filed 2016-11-09
$7.08M
10-Q · filed 2016-11-09
$8.97M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$2.54M
10-Q · filed 2016-07-27
$4.67M
10-Q · filed 2016-07-27
$6.57M
derived: sum of 3 quarters · filed 2017-03-16
$8.23M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.13M
10-Q · filed 2016-05-04
$4.03M
derived: sum of 2 quarters · filed 2017-03-16
$5.69M
derived: sum of 3 quarters · filed 2017-03-16
2014-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$3.56M
derived: sum of 2 quarters · filed 2017-03-16
$7.11M
10-K · filed 2017-03-16
2014-09-30$1.66M
10-Q · filed 2015-11-04
$5.21M
10-Q · filed 2015-11-04
2013-12-31$5.18M
10-K · filed 2016-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Penumbra Inc (PEN)United States$12.596B77.33
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
Solventum Corp (SOLV)United States$15.085B9.16
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B